Li, J., Xie, M., Zhao, R., Qiang, H., Chang, Q., Qian, J., . . . Chu, T. (2024). Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations. Frontiers Media S.A.
Chicago Style (17th ed.) CitationLi, Jiaqi, et al. Anti-angiogenic Therapy or Immunotherapy? A Real-world Study of Patients with Advanced Non-small Cell Lung Cancer with EGFR/HER2 Exon 20 Insertion Mutations. Frontiers Media S.A, 2024.
MLA (9th ed.) CitationLi, Jiaqi, et al. Anti-angiogenic Therapy or Immunotherapy? A Real-world Study of Patients with Advanced Non-small Cell Lung Cancer with EGFR/HER2 Exon 20 Insertion Mutations. Frontiers Media S.A, 2024.
Warning: These citations may not always be 100% accurate.